Bristol Makes Another Cancer Move With Partnering On Phase I MM Antibody
Executive Summary
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the In Vivo blog. Visit the blog at http://invivoblog.blogspot.com/.
You may also be interested in...
Third Time’s Not The Charm For King’s Pursuit of Alpharma
As King Pharmaceuticals tries to move past the hit from the entry of generic competition for Altace and overall lackluster second quarter sales figures, the firm has embarked on a plan to become a powerhouse specialty therapeutic pain company, and a central piece of that plan is the acquisition of Alpharma. But Alpharma will have none of it
GSK Diversifies With Deal That Allows Bristol To Divest Non-Core Unit
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com/.